Cue Biopharma appoints Michael J. Fox to board; grants 48,800-share option

Cue Biopharma, Inc.

Michael J. Fox appointed to Board and Compensation Committee effective June 5, 2024.
Received option to purchase 48,800 shares vesting over three years (1/3 at one year, then quarterly).
Stockholders elected all 7 director nominees; Passeri received 13,099,740 for, 765,119 withheld.
Ratified RSM US LLP as auditor for FY2024 with 32,418,349 for, 1,635,231 against.
Non-binding say-on-pay passed with 11,745,009 for, 1,924,707 against, 20,311,373 broker non-votes.

item 5.02 item 5.07

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael J. Fox

Director

CUE · Cue Biopharma, Inc.

Effective: 2024-06-05
Filed: June 7, 2024, 7:59 PM ET

On June 5, 2024, Michael J. Fox was appointed to the board of directors (the “Board”) and the Compensation Committee of the Board of Cue Biopharma, Inc. (the “Company”), following the recommendation of the Corporate Governance and Nominating Committee of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael J. Fox was appointed as Director at Cue Biopharma, Inc..

Action: appointed
Role: Director

Exact text from the filing

On June 5, 2024, Michael J. Fox was appointed to the board of directors (the “Board”) and the Compensation Committee of the Board of Cue Biopharma, Inc. (the “Company”), following the recommendation of the Corporate Governance and Nominating Committee of the Board.

View on SEC.gov

Cue Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-070566

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.